RE: Metom to answer your question6 Jul 2022 12:03
From page 141 of the annual report:
The RCF is subject to a springing covenant when utilisation is above 35.0%. The covenant requires the Company to maintain a net leverage of 5.0x, tested semi-annually on a 12 months rolling basis. In 2020, the Company secured a covenant waiver on the RCF until June 2022 testing date.
There is absolutely no way that they achieved 5x EBIDTA net leverage on 30th of June. Even under the most optimistic scenario it would be more like 15x. There's no question the covenant has been breached.
That being the case, they either need a waiver, which they have not got, or to pay it down below 35% utilisation, which they also haven't done, per IR comms.
So what is going on and why has nothing been announced?